The United States has suspended some funding for its flagship AIDS relief program, according to international organizations ...

HIV has been in retreat around the world. Fewer people are dying of the disease.New infections are decreasing. More HIV ...

After months of uncertainty, the Trump administration confirmed that it will work with Gilead Sciences and The Global Fund to ...

The plan to target pregnant and breastfeeding mothers will be administered through PEPFAR. Critics said it appeared to ...

HIV has been in retreat around the world. But with cuts to foreign aid, it's less clear where the trend lines go from here. NPR's Ari Shapiro talks to author Emily Bass about the future of the virus.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced a partnership with the U.S. State Department and the United States President’s Emergency Plan for AIDS Relief (PEPFAR) to deliver ...

Through PEPFAR, US will distribute lenacapavir injections to protect pregnant and breastfeeding women and other high-risk groups - Anadolu Ajansı ...

WASHINGTON –– As Republican congressional leaders work to pass the Trump administration's request for $9 billion in spending cuts to foreign aid and public broadcasting, it seemed Wednesday that ...

Senators narrowly saved funding for PEPFAR, the U.S. HIV/AIDS relief program that has saved millions across the globe, as Congress battles the clock to pass vast spending cuts proposed by President ...

The U.S. State Department announced a plan on Thursday to bring Gilead Sciences Inc's drug lenacapavir to market "at cost" in ...

PEPFAR, the campaign to end H.I.V. globally, would morph into an effort to detect disease outbreaks and sell American products, according to documents obtained by The Times. By Stephanie Nolen ...

This follows the announcement by the United States President, Donald Trump’s administration about significant cuts to foreign aid.